282 related articles for article (PubMed ID: 10371538)
1. A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group.
Sachdeo RC; Glauser TA; Ritter F; Reife R; Lim P; Pledger G
Neurology; 1999 Jun; 52(9):1882-7. PubMed ID: 10371538
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
Thiele EA; Marsh ED; French JA; Mazurkiewicz-Beldzinska M; Benbadis SR; Joshi C; Lyons PD; Taylor A; Roberts C; Sommerville K;
Lancet; 2018 Mar; 391(10125):1085-1096. PubMed ID: 29395273
[TBL] [Abstract][Full Text] [Related]
4. Topiramate: a review of its use in childhood epilepsy.
Ormrod D; McClellan K
Paediatr Drugs; 2001; 3(4):293-319. PubMed ID: 11354701
[TBL] [Abstract][Full Text] [Related]
5. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
6. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.
Elterman RD; Glauser TA; Wyllie E; Reife R; Wu SC; Pledger G
Neurology; 1999 Apr; 52(7):1338-44. PubMed ID: 10227615
[TBL] [Abstract][Full Text] [Related]
7. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group.
Biton V; Montouris GD; Ritter F; Riviello JJ; Reife R; Lim P; Pledger G
Neurology; 1999 Apr; 52(7):1330-7. PubMed ID: 10227614
[TBL] [Abstract][Full Text] [Related]
8. Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome.
Glauser T; Kluger G; Sachdeo R; Krauss G; Perdomo C; Arroyo S
Neurology; 2008 May; 70(21):1950-8. PubMed ID: 18401024
[TBL] [Abstract][Full Text] [Related]
9. Topiramate in Lennox-Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Topiramate YL Study Group.
Glauser TA; Levisohn PM; Ritter F; Sachdeo RC
Epilepsia; 2000; 41(S1):86-90. PubMed ID: 10768308
[TBL] [Abstract][Full Text] [Related]
10. Topiramate.
Glauser TA
Semin Pediatr Neurol; 1997 Mar; 4(1):34-42. PubMed ID: 9097365
[TBL] [Abstract][Full Text] [Related]
11. Topiramate as add-on drug in children, adolescents and young adults with Lennox-Gastaut syndrome: an Italian multicentric study.
Coppola G; Caliendo G; Veggiotti P; Romeo A; Tortorella G; De Marco P; Pascotto A
Epilepsy Res; 2002 Sep; 51(1-2):147-53. PubMed ID: 12350390
[TBL] [Abstract][Full Text] [Related]
12. Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.
Devinsky O; Patel AD; Cross JH; Villanueva V; Wirrell EC; Privitera M; Greenwood SM; Roberts C; Checketts D; VanLandingham KE; Zuberi SM;
N Engl J Med; 2018 May; 378(20):1888-1897. PubMed ID: 29768152
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy.
Sharief M; Viteri C; Ben-Menachem E; Weber M; Reife R; Pledger G; Karim R
Epilepsy Res; 1996 Nov; 25(3):217-24. PubMed ID: 8956919
[TBL] [Abstract][Full Text] [Related]
14. Topiramate in medically intractable partial epilepsies: double-blind placebo-controlled randomized parallel group trial. Korean Topiramate Study Group.
Epilepsia; 1999 Dec; 40(12):1767-74. PubMed ID: 10612342
[TBL] [Abstract][Full Text] [Related]
15. Topiramate use in pediatric patients.
Glauser TA
Can J Neurol Sci; 1998 Aug; 25(3):S8-12. PubMed ID: 9706734
[TBL] [Abstract][Full Text] [Related]
16. Preliminary observations on topiramate in pediatric epilepsies.
Glauser TA
Epilepsia; 1997; 38 Suppl 1():S37-41. PubMed ID: 9092958
[TBL] [Abstract][Full Text] [Related]
17. Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome. Lamictal Lennox-Gastaut Study Group.
Motte J; Trevathan E; Arvidsson JF; Barrera MN; Mullens EL; Manasco P
N Engl J Med; 1997 Dec; 337(25):1807-12. PubMed ID: 9400037
[TBL] [Abstract][Full Text] [Related]
18. Topiramate.
Glauser TA
Epilepsia; 1999; 40 Suppl 5():S71-80. PubMed ID: 10530697
[TBL] [Abstract][Full Text] [Related]
19. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Topiramate YD Study Group.
Faught E; Wilder BJ; Ramsay RE; Reife RA; Kramer LD; Pledger GW; Karim RM
Neurology; 1996 Jun; 46(6):1684-90. PubMed ID: 8649570
[TBL] [Abstract][Full Text] [Related]
20. Topiramate. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in the management of epilepsy.
Langtry HD; Gillis JC; Davis R
Drugs; 1997 Nov; 54(5):752-73. PubMed ID: 9360061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
